Market Cap 72.75M
Revenue (ttm) 0.00
Net Income (ttm) -69.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 50,500
Avg Vol 100,476
Day's Range N/A - N/A
Shares Out 28.99M
Stochastic %K 53%
Beta 1.01
Analysts Hold
Price Target $2.50

Latest News on AVTE

Aerovate Therapeutics to Explore Strategic Alternatives

Jul 8, 2024, 8:00 AM EDT - 9 months ago

Aerovate Therapeutics to Explore Strategic Alternatives


Aerovate Therapeutics Readies $100 Million IPO Effort

Jun 28, 2021, 8:00 PM EDT - 4 years ago

Aerovate Therapeutics Readies $100 Million IPO Effort